🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the long-term antibody persistence...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-05-16
Trial ID
NCT00454987
Treatments Being Tested
This study is evaluating the safety and immunogenicity of Hib-MenCY-TT vacc...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-04-11
Trial ID
NCT00134719
Treatments Being Tested
The purpose of this study is to assess the immunogenicity and safety of GSK...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-02-06
Trial ID
NCT01506193
Treatments Being Tested
The purpose of this booster vaccination study is to evaluate the persistenc...
Status
Completed
Location
Multiple Locations
Start Date
2003-01
Trial ID
NCT00135564
Treatments Being Tested
A previous cohort of 93 clinical trial participants received quadrivalent m...
Status
Completed
Location
Multiple Locations
Start Date
2016-12
Trial ID
NCT02811120
Treatments Being Tested
The purpose of the study is to evaluate the immune responses of UK infants ...
Status
Completed
Location
Hertfordshire Primary Care Trusts
Start Date
2005-04
Trial ID
NCT00197808
Treatments Being Tested
The purpose of this study is to compare the reactogenicity \& safety of Tri...
Status
Completed
Location
GSK Investigational Site
Start Date
2003-12-11
Trial ID
NCT00317135
Treatments Being Tested
This protocol posting deals with objectives \& outcome measures of an exten...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-05-14
Trial ID
NCT00891176
This study will evaluate the immunogenicity of the co-administration of dif...
Status
Completed
Location
GSK Investigational Site
Start Date
2003-09-30
Trial ID
NCT00352963
Treatments Being Tested
This protocol posting deals with objectives \& outcome measures of the exte...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-05
Trial ID
NCT00322335